Incoming EMA Chief Throws Weight Behind Antimicrobial Resistance Fight
Executive Summary
Antimicrobial resistance, the lack of new antibiotics, and preserving the effectiveness of existing ones are high on the agenda for the soon-to-be new head of the European Medicines Agency, Emer Cooke.
You may also be interested in...
Coronavirus Notebook: Moderna Claims 94.5% Vaccine Efficacy, Janssen Starts Second ENSEMBLE Trial
The European Medicines Agency has begun a rolling review of Moderna’s mRNA vaccine, and its new executive director, Emer Cooke, has taken up her role with a promise to make tackling COVID-19 her “number one priority.”
‘Unprecedented’ EMA Response To COVID-19 Must Be Sustained
The agility, flexibility and transparency that the European Medicines Agency has adopted during the development and assessment of COVID-19 products will have to continue after treatments and vaccines are on the market, says the soon-to-be new head of the agency, Emer Cooke.
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: